Alligator Bioscience invites to a virtual R&D Day on August 27 at 2:00 p.m. - 3:00 p.m., in which CEO Per Norlén and COO Malin Carlsson will give an update on the status and latest development steps in the company’s clinical pipeline - focusing on the drug candidates mitazalimab, ATOR-1015 and ATOR-1017.
August 25, 2020
· 2 min read